TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 14677160

Group type: EXPERIMENTAL
Intervention: Group I: actual LPLT (5 minutes, 3 J total dose + exercise)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group II: actual LPLT (3 minutes, 2 J total dose + exercise)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group III: placebo laser group + exercise
Number of subjects: 90
Study: 11020511

Group type: EXPERIMENTAL
Intervention: DSG 150-T 100
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: DSG 300-T 100
Number of subjects: 24

Group type: COMPARATOR
Intervention: DSG 150-T 100, DSG 300-T 100, LNG 125-T 100
Number of subjects: 24

Group type: COMPARATOR
Intervention: DSG 300-T 100, LNG 125-T 100
Number of subjects: 24
Study: 8835876

Group type: EXPERIMENTAL
Intervention: Immunosuppressive agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conventional medical regimens
Number of subjects: 0
Study: 1413847

Group type: COMPARATOR
Intervention: Bilateral subtotal resection (n = 23)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hemithyroidectomy plus contralateral resection (n = 27)
Number of subjects: 50
Study: 2982882

Group type: EXPERIMENTAL
Intervention: Chemotherapy with vincristin, methotrexate, and cyclophosphamide
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Chemotherapy with vincristin, methotrexate, and cyclophosphamide plus systemic immunotherapy with Propionibacterium granulosum strain KP-45
Number of subjects: 79

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 79
Study: 31497011

Group type: EXPERIMENTAL
Intervention: Iron sucrose (non-dialysis group)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Ferric carboxymaltose (non-dialysis group)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Iron sucrose (dialysis group)
Number of subjects: 83

Group type: COMPARATOR
Intervention: No IV iron (dialysis group)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: IV iron (both groups)
Number of subjects: 83
Study: 29059068

Group type: EXPERIMENTAL
Intervention: Armeo robotic therapy (12 weeks, 45 min/session, 3 days/week)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional therapy (12 weeks)
Number of subjects: 30
Study: 26935357

Group type: EXPERIMENTAL
Intervention: Aflibercept
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 660

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 660

Group type: COMPARATOR
Intervention: Focal/grid laser photocoagulation
Number of subjects: 660

Group type: COMPARATOR
Intervention: Baseline VA worse (20/50 to 20/320)
Number of subjects: 660

Group type: COMPARATOR
Intervention: Baseline VA better (20/32 to 20/40)
Number of subjects: 660
Study: 25028689

Group type: EXPERIMENTAL
Intervention: UltraEZ (KNO3)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: MI Paste (CPP-ACP)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo of UltraEZ
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo of MI Paste
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: UltraEZ and MI Paste
Number of subjects: 102
Study: 22469559

Group type: EXPERIMENTAL
Intervention: Bortezomib-melphalan-prednisone (VMP; nine 6-wk cycles)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Melphalan-prednisone (MP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bortezomib dose intensity
Number of subjects: 0
Study: 20634754

Group type: EXPERIMENTAL
Intervention: Mixed-intensity interval endurance training (MI-ET)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Circuit-interval resistance training (CRT)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Traditional continuous endurance training (ET)
Number of subjects: 13
Study: 17693373

Group type: EXPERIMENTAL
Intervention: Passive self-ligating SmartClip brackets
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional twin brackets ligated with stainless steel ligatures
Number of subjects: 19
Study: 15780117

Group type: EXPERIMENTAL
Intervention: Predilution hemodiafiltration (HDF)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-flux hemodialysis
Number of subjects: 12
Study: 12372680

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 11887892

Group type: EXPERIMENTAL
Intervention: Simulated push-pull effect (PPE) test with head-up stand (HUT, +1 Gz) for 1 min, head-down stand (HDT, -1 Gz) for 30 s, and HUT combining LBNP (-50 mmHg) for 10 min.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control test with HUT combining LBNP (-50 mmHg) for 10 min.
Number of subjects: 8
Study: 9620386

Group type: EXPERIMENTAL
Intervention: Premier E. coli O157
Number of subjects: 876

Group type: EXPERIMENTAL
Intervention: Premier EHEC
Number of subjects: 876

Group type: COMPARATOR
Intervention: Standard culture (control)
Number of subjects: 876

Group type: EXPERIMENTAL
Intervention: Non-O157 verotoxin-producing E. coli
Number of subjects: 876
Study: 8141435

Group type: EXPERIMENTAL
Intervention: Theophylline (5 mg/kg body weight intravenous infusion over 20 min, followed by 1 mg/kg per hour)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Theophylline at subtherapeutic concentrations (5 micrograms/ml)
Number of subjects: 20
Study: 2449871

Group type: EXPERIMENTAL
Intervention: Iloprost infusion
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 29
Study: 31296328

Group type: EXPERIMENTAL
Intervention: Postoperative rectal tube for 5 days (Group A)
Number of subjects: 383

Group type: COMPARATOR
Intervention: No postoperative rectal tube (Group B)
Number of subjects: 383
Study: 29606547

Group type: EXPERIMENTAL
Intervention: Aerobic training (20-45 min walking or running at 50-70% of heart rate reserve, 3 sessions per week for 12 weeks)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Aerobic training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no aerobic training)
Number of subjects: 24
Study: 29079227

Group type: EXPERIMENTAL
Intervention: Docetaxel chemotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Abiraterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional androgen deprivation
Number of subjects: 0
Study: 25920503

Group type: EXPERIMENTAL
Intervention: Task-oriented treadmill-walking training (TOTWT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional treadmill-walking training (CTWT)
Number of subjects: 0
Study: 22570252

Group type: EXPERIMENTAL
Intervention: Decision Navigation (DN)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Usual Care (Control)
Number of subjects: 123
Study: 21511276

Group type: EXPERIMENTAL
Intervention: LY2216684 6-18 mg once daily
Number of subjects: 495

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 495
Study: 17956931

Group type: COMPARATOR
Intervention: Minimal Intervention Bibliotherapy Treatment (MIT)
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: 12-session parenting program led by a nurse or psychologist
Number of subjects: 117
Study: 17199766

Group type: EXPERIMENTAL
Intervention: Dermal thermometry (DT) with a skin temperature differential of > or =10 degrees F at baseline
Number of subjects: 332

Group type: EXPERIMENTAL
Intervention: Dermal thermometry (DT) with a skin temperature differential of <10 degrees F at baseline
Number of subjects: 332

Group type: COMPARATOR
Intervention: Baseline skin temperature differential
Number of subjects: 332

Group type: COMPARATOR
Intervention: Skin temperature differential at baseline
Number of subjects: 332
Study: 14615738

Group type: EXPERIMENTAL
Intervention: Vitamin A therapy (administered intramuscularly on days 1, 3, and 7)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vitamin A therapy
Number of subjects: 40
Study: 10979640

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg daily for 12 weeks
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Losartan 25 mg daily for 12 weeks
Number of subjects: 96

Group type: COMPARATOR
Intervention: Basic therapy + long-acting nitrates, digoxin, aspirin, and furosemide
Number of subjects: 96
Study: 8637340

Group type: EXPERIMENTAL
Intervention: Subcutaneous standard heparin (5000 IU every 12 h) until hospital discharge or for a maximum of 3 weeks
Number of subjects: 5776

Group type: COMPARATOR
Intervention: No prophylactic treatment (control group)
Number of subjects: 5776
Study: 1593573

Group type: EXPERIMENTAL
Intervention: Misoprostol (800 micrograms/day for one week)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Misoprostol
Number of subjects: 13
Study: 30528641

Group type: EXPERIMENTAL
Intervention: Exercise intervention (concurrent training: power training + high-intensity interval training, HIIT)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 20
Study: 30069910

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 1204
Study: 26376112

Group type: EXPERIMENTAL
Intervention: Hi-PRO (1.5 g milk protein/100 mL)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Lo-PRO (0.76 g milk protein/100 mL)
Number of subjects: 15

Group type: COMPARATOR
Intervention: CONT (0 g milk protein/100 mL)
Number of subjects: 15
Study: 25249697

Group type: EXPERIMENTAL
Intervention: Psychological stress (Trier Social Stress Test)
Number of subjects: 28
Study: 22337460

Group type: EXPERIMENTAL
Intervention: Amcrylate (iso amyl 2‐cyanoacrylate)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 6‐0 Prolene (sutures)
Number of subjects: 60
Study: 25885382

Group type: EXPERIMENTAL
Intervention: Gabapentin 10 mg/kg
Number of subjects: 70

Group type: COMPARATOR
Intervention: Paracetamol 20 mg/kg
Number of subjects: 70
Study: 16928714

Group type: EXPERIMENTAL
Intervention: Management pathway to improve early delivery of appropriate antibiotics, implemented using a multifaceted strategy.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control site (no specific intervention mentioned).
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis of the intervention.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis of preventing death.
Number of subjects: 0
Study: 16119522

Group type: EXPERIMENTAL
Intervention: Urine protein to osmolality ratio (Uprot/Uosm)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Urine protein to creatinine ratio (Up/Ucr)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Random urine specimens (Uprot/Uosm and Up/Ucr)
Number of subjects: 150
Study: 12108850

Group type: EXPERIMENTAL
Intervention: Inhaled budesonide
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (untreated patients)
Number of subjects: 0
Study: 12024361

Group type: EXPERIMENTAL
Intervention: Primary prevention strategies for neural tube defects
Number of subjects: 0
Study: 7547016

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 618

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Metoprolol and Placebo
Number of subjects: 618
Study: 1689512

Group type: EXPERIMENTAL
Intervention: Oral rinse consisting of hydrocortisone, nystatin, tetracycline, and diphenhydramine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control rinse
Number of subjects: 0
Study: 7368106

Group type: EXPERIMENTAL
Intervention: Metronidazole (2 gm the day before operation and 1.2 gm daily for 5 days after operation)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo (same dosage as metronidazole)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 28273681

Group type: COMPARATOR
Intervention: Glazing group (control)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Grinding-glazing group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Grinding-D+Z group
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Grinding-OptraFine group
Number of subjects: 52
Study: 29065875

Group type: EXPERIMENTAL
Intervention: Examiner scores and feedback for Asian students
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Response times to Asian-stereotypical vs neutral words
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Recognition rates for real vs invented stereotype-consistent vs stereotype-inconsistent phrases
Number of subjects: 0
Study: 25673013

Group type: EXPERIMENTAL
Intervention: Web‐Only
Number of subjects: 141429

Group type: COMPARATOR
Intervention: Phone/Web
Number of subjects: 141429

Group type: EXPERIMENTAL
Intervention: Both programs
Number of subjects: 141429
Study: 24956042

Group type: EXPERIMENTAL
Intervention: Quetiapine XR (150-300 mg/day)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Quetiapine XR
Number of subjects: 193
Study: 22609540

Group type: EXPERIMENTAL
Intervention: Counseling plus mixing-point masking
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Counseling plus total masking
Number of subjects: 48

Group type: COMPARATOR
Intervention: Counseling alone
Number of subjects: 48
Study: 19340676

Group type: EXPERIMENTAL
Intervention: CBT+naltrexone
Number of subjects: 298

Group type: COMPARATOR
Intervention: CBT
Number of subjects: 298
Study: 17707752

Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (three 5‐min cycles of right upper limb ischaemia, inflated to 200 mm Hg)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 57
Study: 15631969

Group type: EXPERIMENTAL
Intervention: Computer training
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Good knowledge of computers
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Good attitude and utilization habits
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Good computer knowledge among students and doctors
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Good utilization habits and attitudes
Number of subjects: 180
Study: 11520780

Group type: EXPERIMENTAL
Intervention: PEG‐rHuMGDF 1 microg/kg
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: PEG‐rHuMGDF 3 microg/kg
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 9576164

Group type: EXPERIMENTAL
Intervention: Midazolam (2.0 mg for ≤50 kg, 2.5 mg for 50-80 kg, 3.0 mg for ≥80 kg)
Number of subjects: 200
Study: 7835449

Group type: EXPERIMENTAL
Intervention: 9/0 elastic polypropylene sutures
Number of subjects: 52

Group type: COMPARATOR
Intervention: 10/0 nylon sutures
Number of subjects: 52
Study: 3170985

Group type: EXPERIMENTAL
Intervention: Extract prepared from whole mite culture (WMC)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Extract from purified mite bodies (MB)
Number of subjects: 24
Study: 31969138

Group type: EXPERIMENTAL
Intervention: Medication Errors (ME) observed in patients
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Types of Medication Errors
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Drug associated with ME
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: Adverse events
Number of subjects: 311
Study: 30086277

Group type: EXPERIMENTAL
Intervention: Clomipramine 15 mg
Number of subjects: 159

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 159
Study: 28228148

Group type: EXPERIMENTAL
Intervention: 25mg melatonin
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 25840503

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) for 12 weeks
Number of subjects: 16

Group type: COMPARATOR
Intervention: Continued Moderate Training (CON) for 12 weeks
Number of subjects: 16
Study: 24968543

Group type: EXPERIMENTAL
Intervention: Unfractionated heparin (UFH)
Number of subjects: 92

Group type: COMPARATOR
Intervention: Low‐molecular weight heparin (LMWH)
Number of subjects: 92
Study: 21328002

Group type: EXPERIMENTAL
Intervention: Totally implantable hearing devices (Esteem, Envoy system)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Implanted device (Esteem, Envoy system)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Pre-operative temporal bone CT scan anatomy
Number of subjects: 10
Study: 19605530

Group type: EXPERIMENTAL
Intervention: Physostigmine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17019627

Group type: EXPERIMENTAL
Intervention: DTkid training
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Observation of DTkid training trials
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 0
Study: 16336486

Group type: EXPERIMENTAL
Intervention: BSW (patient-rated global assessment of treatment benefit)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: BSW
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Patients dissatisfied with treatment
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Patients unwilling to continue treatment
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: BSW measures
Number of subjects: 3
Study: 12587378

Group type: EXPERIMENTAL
Intervention: Surgery and concurrent chemoradiotherapy
Number of subjects: 281

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 281
Study: 10099057

Group type: EXPERIMENTAL
Intervention: Iscador (twice 0.1 mg and once 2.5 mg)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Iscador (2.5 mg)
Number of subjects: 7
Study: 7855376

Group type: EXPERIMENTAL
Intervention: Prolonged inflation (13.5 +/- 3.3 min) at 6 atmospheres using an autoperfusion catheter
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard inflations (3.1 +/- 1.6 min) using conventional catheters
Number of subjects: 153
Study: 2679374

Group type: EXPERIMENTAL
Intervention: Pefloxacin (400 mg i.v. or per os every 8 or 12 h for 7 to 180 days)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Ceftazidime (2 g i.v. every 8 h or 1 g intramuscularly every 8 h for 7 to 56 days)
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Pefloxacin
Number of subjects: 103

Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 103
Study: 941075

Group type: EXPERIMENTAL
Intervention: Percutaneous peritoneal dialysis
Number of subjects: 300

Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Objective early identification of severe pancreatitis
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Overall management improvements
Number of subjects: 300
Study: 31159727

Group type: EXPERIMENTAL
Intervention: galcanezumab
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: erenumab
Number of subjects: 16
Study: 28793042

Group type: EXPERIMENTAL
Intervention: MP‐TLH (total laparoscopic hysterectomy with 3 abdominal incisions)
Number of subjects: 42

Group type: COMPARATOR
Intervention: SP‐TLH (total laparoscopic hysterectomy with a single umbilical incision)
Number of subjects: 42
Study: 26042336

Group type: EXPERIMENTAL
Intervention: TURis bipolar vaporization
Number of subjects: 84

Group type: COMPARATOR
Intervention: Monopolar TURP
Number of subjects: 84
Study: 23265980

Group type: EXPERIMENTAL
Intervention: Cyclofem (medroxyprogesterone acetate and estradiol cypionate)
Number of subjects: 15
Study: 21623465

Group type: EXPERIMENTAL
Intervention: Telemedicine intervention for diabetes management
Number of subjects: 2169

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2169
Study: 18461430

Group type: EXPERIMENTAL
Intervention: PVI with double transseptal puncture
Number of subjects: 31
Study: 16009588

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol (320/9 microg, two inhalations; total doses 1280/36 microg)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Salbutamol (100 microg x eight inhalations; total doses 1600 microg)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Salbutamol (control)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol
Number of subjects: 104
Study: 12915742

Group type: EXPERIMENTAL
Intervention: HFA‐134a beclomethasone dipropionate (HFA‐BDP) 400 microg b.i.d.
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 375 microg b.i.d.
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control (washout period)
Number of subjects: 41
Study: 10881757

Group type: EXPERIMENTAL
Intervention: Experimental gown
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control drape
Number of subjects: 69
Study: 8998256

Group type: EXPERIMENTAL
Intervention: Isradipine or Diltiazem
Number of subjects: 11
Study: 2238665

Group type: COMPARATOR
Intervention: Neomycin and erythromycin (1 g each) administered preoperatively to Group B patients.
Number of subjects: 31

Group type: COMPARATOR
Intervention: Cefoxitin or cefotetan (2 g intravenously) administered preoperatively to Group C patients.
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Combination of oral and parenteral antibiotics in Group D patients.
Number of subjects: 31
Study: 678048

Group type: EXPERIMENTAL
Intervention: Methadyl acetate
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 28

Group type: COMPARATOR
Intervention: Nondrug users
Number of subjects: 28
Study: 31727428

Group type: EXPERIMENTAL
Intervention: Tube shunt (350-mm2 Baerveldt glaucoma implant)
Number of subjects: 242

Group type: COMPARATOR
Intervention: Trabeculectomy with mitomycin C (MMC; 0.4 mg/ml for 2 minutes)
Number of subjects: 242

Group type: EXPERIMENTAL
Intervention: Tube shunt
Number of subjects: 242

Group type: COMPARATOR
Intervention: Trabeculectomy
Number of subjects: 242
Study: 31053788

Group type: EXPERIMENTAL
Intervention: Top 10% Human Phenotype Ontology (HPO) IDs based on information content
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Top 30% Human Phenotype Ontology (HPO) IDs based on information content
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Top 50% Human Phenotype Ontology (HPO) IDs based on information content
Number of subjects: 50

Group type: COMPARATOR
Intervention: Randomly chosen Human Phenotype Ontology (HPO) IDs
Number of subjects: 50
Study: 28785810

Group type: EXPERIMENTAL
Intervention: Splint + paraffin treatment (five consecutive days a week for 3 weeks)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Splint treatment (during the night and day time as much as possible for 3 weeks)
Number of subjects: 70
Study: 23749244

Group type: EXPERIMENTAL
Intervention: 4 mg zoledronic acid every 6 months over 3 years
Number of subjects: 63
Study: 22363056

Group type: EXPERIMENTAL
Intervention: Postmenopausal hormone therapy
Number of subjects: 455
Study: 19952403

Group type: EXPERIMENTAL
Intervention: Aminophylline (5 mg/kg) injected slowly via the vein after anesthesia and maintained at 0.5 mg/(kg.h) until the end of CPB
Number of subjects: 40

Group type: COMPARATOR
Intervention: Ringer's lactated solution (control group)
Number of subjects: 40